Franzmann, Alexandra
Referentin für Statistik [bis 2012], Deutsches Arzneiprüfungsinstitut e. V. (DAPI), Eschborn [bis 2012]
- 2002 - 2012 Referentin für Statistik am Deutschen Arzneiprüfungsinstitut (DAPI), Eschborn
Publications
- Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany
- Medication persistence with ginkgo biloba drugs of different dosage strengths - Persistenz bei Ginkgo biloba-Arzneimitteln unterschiedlicher Wirkstärke.
- Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study.
- Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
- Incidence of thyroid hormone therapy in patients treated with sorafenib or sunitinib
- Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
- Utilizing claims data to assess persistence with antidepressants.
- Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin. (1)
- Pharmacy refill adherence with antidepressants.
- Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany
- Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany (1)
- Beeinflusst die Umstellung von Risedronat oder Alendronat Originalprodukten auf Generika die Compliance (Persistenz)?
- Non-Compliance – das unterschätzte Problem: Neue Möglichkeiten der Erfassung über Datenbankanalysen
- Zielpreise für Leitsubstanzen: Verantwortungsteilung zwischen Arzt und Apotheker
- Marktanteilsanalyse zum TK-Rabattvertrag
- Marktanteilsanalyse zum AOK-Rabattvertrag
- Statine – Verordnungsanalyse und Praxistipps